These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 19730116

  • 1. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
    Fukuhara T, Hiyama T, Tanaka S, Oka S, Yoshihara M, Arihiro K, Chayama K.
    J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
    [Abstract] [Full Text] [Related]

  • 2. Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection.
    Urabe Y, Hiyama T, Tanaka S, Oka S, Yoshihara M, Arihiro K, Chayama K.
    Endoscopy; 2009 Apr; 41(4):304-9. PubMed ID: 19340732
    [Abstract] [Full Text] [Related]

  • 3. Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer.
    Hori K, Okada H, Kawahara Y, Takenaka R, Shimizu S, Ohno Y, Onoda T, Sirakawa Y, Naomoto Y, Yamamoto K.
    Am J Gastroenterol; 2011 May; 106(5):858-66. PubMed ID: 21468010
    [Abstract] [Full Text] [Related]

  • 4. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
    Katada C, Muto M, Nakayama M, Tanabe S, Higuchi K, Sasaki T, Azuma M, Ishido K, Katada N, Yamashita K, Nemoto M, Shibata T, Masaki T, Okamoto M, Koizumi W.
    Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
    [Abstract] [Full Text] [Related]

  • 5. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S.
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [Abstract] [Full Text] [Related]

  • 6. Natural course of lugol-voiding lesions in patients with superficial esophageal squamous cell carcinoma.
    Fukuhara T, Hiyama T, Tanaka S, Oka S, Yoshihara M, Arihiro K, Chayama K.
    Digestion; 2010 Oct; 82(1):60-5. PubMed ID: 20203512
    [Abstract] [Full Text] [Related]

  • 7. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
    Chow TL, Lee DT, Choi CY, Chan TT, Lam SH.
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
    [Abstract] [Full Text] [Related]

  • 8. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
    Matsuno K, Ishihara R, Nakagawa K, Ohmori M, Iwagami H, Inoue S, Iwatsubo T, Nakahira H, Matsuura N, Shichijyo S, Maekawa A, Takashi K, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Matsunaga T.
    J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H, Chiba H, Tachikawa J, Okada N, Ashikari K, Arimoto J, Nakaoka M, Sakai E, Goto T, Ohata K.
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [Abstract] [Full Text] [Related]

  • 10. Head and neck cancer arising after endoscopic mucosal resection for squamous cell carcinoma of the esophagus.
    Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Watanabe A, Kawabori S, Kato M, Sugiyama T, Asaka M.
    Endoscopy; 2003 Apr; 35(4):322-6. PubMed ID: 12664389
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma.
    Katada C, Muto M, Tanabe S, Higuchi K, Sasaki T, Azuma M, Ishido K, Katada N, Sakuramoto S, Yamashita K, Masaki T, Nakayama M, Okamoto M, Koizumi W.
    Dis Esophagus; 2014 Jul; 27(5):457-62. PubMed ID: 23009284
    [Abstract] [Full Text] [Related]

  • 12. Narrow-band imaging provides reliable screening for esophageal malignancy in patients with head and neck cancers.
    Takenaka R, Kawahara Y, Okada H, Hori K, Inoue M, Kawano S, Tanioka D, Tsuzuki T, Uemura M, Ohara N, Tominaga S, Onoda T, Yamamoto K.
    Am J Gastroenterol; 2009 Dec; 104(12):2942-8. PubMed ID: 19623169
    [Abstract] [Full Text] [Related]

  • 13. [Incidence of esophageal cancer synchronous with upper aerodigestive tract cancers (100 cases): value of vital staining with lugol and toluidine blue].
    Papazian A, Descombes P, Capron JP, Lorriaux A.
    Gastroenterol Clin Biol; 1985 Jan; 9(1):16-22. PubMed ID: 3979722
    [Abstract] [Full Text] [Related]

  • 14. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
    Katada C, Yokoyama T, Yano T, Kaneko K, Oda I, Shimizu Y, Doyama H, Koike T, Takizawa K, Hirao M, Okada H, Yoshii T, Konishi K, Yamanouchi T, Tsuda T, Omori T, Kobayashi N, Shimoda T, Ochiai A, Amanuma Y, Ohashi S, Matsuda T, Ishikawa H, Yokoyama A, Muto M.
    Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
    [Abstract] [Full Text] [Related]

  • 15. Detection of metachronous esophageal squamous carcinoma in patients with head and neck cancer with use of transnasal esophagoscopy.
    Su YY, Fang FM, Chuang HC, Luo SD, Chien CY.
    Head Neck; 2010 Jun; 32(6):780-5. PubMed ID: 19890910
    [Abstract] [Full Text] [Related]

  • 16. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H, Yano T, Yoda Y, Oono Y, Ikematsu H, Hayashi R, Ohtsu A, Kaneko K.
    World J Gastroenterol; 2017 Feb 14; 23(6):1051-1058. PubMed ID: 28246479
    [Abstract] [Full Text] [Related]

  • 17. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.
    Fagundes RB, de Barros SG, Pütten AC, Mello ES, Wagner M, Bassi LA, Bombassaro MA, Gobbi D, Souto EB.
    Endoscopy; 1999 May 14; 31(4):281-5. PubMed ID: 10376452
    [Abstract] [Full Text] [Related]

  • 18. Abrasive esophageal cytology for the oncological follow-up of patients with head and neck cancer.
    Pellanda A, Grosjean P, Leoni S, Mihaescu A, Monnier P, Pasche P.
    Laryngoscope; 1999 Oct 14; 109(10):1703-8. PubMed ID: 10522946
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of unsedated transnasal endoscopy with white-light, flexible spectral imaging color enhancement, and lugol staining for esophageal cancer screening in high-risk patients.
    Arantes V, Albuquerque W, Salles JM, Freitas Dias CA, Alberti LR, Kahaleh M, Ferrari TC, Coelho LG.
    J Clin Gastroenterol; 2013 Apr 14; 47(4):314-21. PubMed ID: 23059405
    [Abstract] [Full Text] [Related]

  • 20. Effect of routine esophageal screening in patients with head and neck cancer.
    Su YY, Chen WC, Chuang HC, Guo CS, Lin YT, Luo SD, Fang FM, Chien CY.
    JAMA Otolaryngol Head Neck Surg; 2013 Apr 14; 139(4):350-4. PubMed ID: 23519755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.